生物基轮胎市场：2026-2032年全球预测（按轮胎类型、结构、材料类型和应用划分）

预计到 2025 年，生物基轮胎市场价值将达到 38.1 亿美元，到 2026 年将成长至 41.1 亿美元，到 2032 年将达到 74.2 亿美元，年复合成长率为 9.97%。

关键市场统计数据
基准年 2025	38.1亿美元
预计年份：2026年	41.1亿美元
预测年份 2032	74.2亿美元
复合年增长率 (%)	9.97%

对永续性、材料创新和营运准备日益增长的需求，正促使人们重新思考传统的轮胎原料。

生物基轮胎产业正处于材料科学、永续性政策和全球价值链趋势相互融合，重新定义轮胎製造价值的阶段。随着汽车製造商和轮胎製造商评估轮胎全生命週期影响，传统合成聚合物和石油基成分的替代品正变得越来越有吸引力。同时，监管机构、车队营运商和具有环保意识的消费者日益严格的审查，也促使人们重新评估原料采购和报废处理策略。

材料科学的不断发展、监管奖励的出台以及采购重点的转变，正在推动製造业和供应链策略向采用生物基轮胎解决方案的方向发展。

目前，该产业正经历一场由三大核心力量驱动的变革：生物基复合材料技术的成熟、降低碳足迹的监管压力，以及车队营运商和汽车製造商商业性优先事项的转变。生物基聚合物和改质天然橡胶的进步正在缩小其与合成替代品在弹性、湿地抓地力等性能指标上的差距，从而降低了曾经限制这些材料应用于小众领域的技术壁垒。

贸易政策调整可能会促使供应链重组和筹资策略转变，这可能会影响生物基轮胎材料的采用路径。

关税和贸易调整的实施会显着改变原料和成品的供应链结构，产生连锁反应，影响采购决策和生产地点的选择。关税结构的变化往往促使製造商重新评估进口成品轮胎与部分生产过程化的相对吸引力，并重新评估与供应商的关係，以降低关税波动带来的风险。

轮胎类型、终端使用管道、材料成分和结构类型的不同应用模式指南有针对性的商业化策略。

细分市场分析揭示了不同轮胎类型、终端使用者管道、材料类别和製造流程的采用趋势，这些差异对于确定商业化工作的优先顺序至关重要。例如，按轮胎类型划分，市场可分为重型商用车、轻型商用车、越野车、乘用车和两轮车，不同类别的采用时间表和性能优先级差异显着。重型商用车应用高度重视承载能力和翻新性能，而乘用车市场则更注重滚动阻力和噪音特性。

区域法规结构、原料供应和产业生态系统决定了美洲、欧洲、中东和非洲以及亚太地区的不同商业化路径。

区域趋势在塑造供应链、监管环境和客户期望方面发挥着至关重要的作用，因此，在规划生产计画和市场准入时，了解地域差异至关重要。在美洲，车队电气化试点和永续性措施带来的日益增长的需求压力，为低滚动阻力和生物基复合材料技术创造了独特的机会。同时，北美地区的生产能力和原料取得管道正在影响新复合材料融入生产线的速度。

每家公司都结合了专有材料开发、上游原料伙伴关係和製造柔软性，以加速性能检验和商业化。

产业主要参与者正在研发、供应链整合和商业化等领域寻求差异化策略。一些公司优先投资于专有的生物基聚合物配方技术和性能优化，以期在保持操控性能和耐久性的同时，将产品从实验室阶段推进到中试阶段。这些投资通常会与原始设备製造商 (OEM) 和车队营运商进行联合试验计画，以收集长期性能数据，并在实际工况下检验产品的可修復性和可翻新性。

优先考虑实际的研发检验、稳健的材料筹资策略和模组化製造流程升级，对于降低商业化风险和满足原始设备製造商 (OEM) 和监管机构的期望至关重要。

产业领导者应优先制定切实可行的行动计划，兼顾技术严谨性和商业性现实性。首先，应投入专案研发资源，解决对终端使用者至关重要的效能差距，例如湿地抓地力和滚动阻力。同时，应维持严格的测试机制，包括对代表性车队进行长期实地检验。此外，还应结合结构化的试验计画，制定明确的成功标准和资料共用通讯协定，以加速OEM认证进程。

我们将采用混合方法，结合初步访谈、实验室检验审查和营运试点评估，使技术可行性与商业性现实相符。

本分析整合了质性访谈、材料科学文献和跨职能运作标竿分析，从而对商业化动态进行了严谨的剖析。关键输入包括对材料科学家、采购主管、生产工程师和车队营运经理的结构化访谈，并辅以现场考察和试验计画总结，从而深入了解製造整合挑战和实际性能权衡。

迭代技术检验、切合实际的供应链调整以及合作伙伴关係将决定哪些组织主导商业性可行的生物基轮胎解决方案的过渡。

生物基轮胎的未来发展道路并非线性或同质化的，而是由技术迭代进步、有针对性的商业试点以及区域性供应链选择共同决定的。儘管技术进步正在稳步缩小效能差距，但要实现广泛应用，仍需持续投资于检验项目，将实验室的改进转化为可验证的运作可靠性。同时，监管力道和采购重点的转变也促使製造商将环境绩效融入其核心产品理念。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按轮胎类型分類的生物基轮胎市场

• 大型商用车辆
• 轻型商用车
• 越野
• 搭乘用车
• 摩托车

第九章 生物基轮胎市场结构分析

• 偏见
• 径向

第十章 依材料类型分類的生物基轮胎市场

• 生物基聚合物
• 天然橡胶
• 合成橡胶

第十一章 依最终用途分類的生物基轮胎市场

• OEM
• 用于替换

第十二章 各地区生物基轮胎市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 生物基轮胎市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国生物基轮胎市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章美国生物基轮胎市场

第十六章 中国生物基轮胎市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Apollo Tyres Limited
• Birla Carbon
• Bridgestone Corporation
• CEAT Limited
• Compagnie Generale des Etablissements Michelin SCA
• Continental Aktiengesellschaft
• Evonik Industries AG
• Hankook Tire & Technology Co., Ltd.
• JK Tyre & Industries Ltd.
• Kumho Tire Co., Inc.
• Pirelli & CSpA
• Sailun Group Co., Ltd.
• Solvay
• Sumitomo Rubber Industries, Ltd.
• The Goodyear Tire & Rubber Company
• Titan International, Inc.
• Toyo Tire Corporation
• Yokohama Rubber Co., Ltd.

The Biobased Tires Market was valued at USD 3.81 billion in 2025 and is projected to grow to USD 4.11 billion in 2026, with a CAGR of 9.97%, reaching USD 7.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 3.81 billion
Estimated Year [2026]	USD 4.11 billion
Forecast Year [2032]	USD 7.42 billion
CAGR (%)	9.97%

A converging moment for materials innovation and operational readiness as sustainability demands accelerate reconsideration of traditional tire raw materials

The biobased tires landscape is entering a phase where materials science, sustainability policy, and global supply chain dynamics converge to redefine what constitutes value in tire manufacturing. As automakers and tire makers evaluate lifecycle impacts, the appeal of alternatives to conventional synthetic polymers and petroleum-derived components is sharpening. At the same time, rising scrutiny from regulators, fleet operators, and environmentally conscious consumers is driving a reassessment of raw material sourcing and end-of-use strategies.

Transitioning from concept to commercial viability requires alignment across multiple stakeholders: polymer chemists refining bio-based formulations, production engineers adapting compounding and curing processes, and procurement teams restructuring supplier relationships to accommodate novel feedstocks. Moreover, integration challenges extend to testing and certification, where durability, rolling resistance, and wet grip must meet established criteria without compromising environmental gains. Therefore, successful entrants are those who balance technical performance with pragmatic manufacturing pathways that minimize disruption to existing lines.

Taken together, these dynamics create a high-impact environment where strategic investment in R&D, collaborative pilot programs with vehicle OEMs, and clear sustainability narratives are essential. Organizations that build cross-functional capabilities and demonstrate credible performance parity will be best positioned to convert emerging interest into durable commercial uptake.

Evolving material science, regulatory incentives, and procurement priorities are collectively shifting manufacturing and supply chain strategies toward adoption of biobased tire solutions

The industry is experiencing transformative shifts driven by three core forces: technological maturation of bio-based formulations, regulatory pressure toward lower carbon footprints, and evolving commercial priorities among fleet operators and automakers. Advances in bio-based polymers and modified natural rubbers are delivering closer parity with synthetic alternatives on metrics such as resilience and wet traction, which reduces the technical impediments that once confined these materials to niche applications.

Simultaneously, regulatory pathways in many jurisdictions are sharpening life-cycle scrutiny and incentivizing lower embodied carbon. This encourages integration of biogenic feedstocks, circularity features, and end-of-life recovery schemes into the product design brief. Moreover, procurement leaders are beginning to assign higher strategic value to environmental attributes, which in turn increases the willingness of OEMs to specify alternative-material tires for both passenger and commercial segments.

Consequently, supply chains are being reconfigured: raw material suppliers are investing in feedstock traceability and scalable production, while tire manufacturers are piloting modified compounding lines and partnering with fleet customers on validation programs. In short, the market is moving from proof-of-concept toward staged commercialization, and the organizations that orchestrate cross-industry partnerships will capture early credibility and market momentum.

Trade policy adjustments can catalyze supply chain reconfiguration and procurement strategy shifts that influence the adoption pathways for biobased tire materials

The introduction of tariffs and trade adjustments can materially alter supply chain calculus for both raw materials and finished products, producing ripple effects that influence sourcing decisions and production footprints. When duty structures change, manufacturers reassess the relative attractiveness of importing finished tires versus domesticizing certain stages of production, and they often re-evaluate supplier relationships to reduce exposure to tariff volatility.

In the automotive supply chain, these adjustments can accelerate vertical integration moves or prompt regionalization strategies that prioritize proximity to OEM assembly plants and major fleet customers. For example, where increased duties affect polymer or rubber imports, producers may prioritize long-term contracts with local feedstock providers or invest in alternate feedstocks that are exempt or subject to more favorable treatment. Likewise, tariff-driven cost pressures can incentivize upgrades in process efficiency to preserve margin without recourse to reducing product performance.

Moreover, companies respond to tariff shifts by sharpening scenario planning and enhancing contractual terms with suppliers to include clauses for duty mitigation or pass-through. In parallel, procurement and finance teams intensify hedging mechanisms and evaluate capacity investments that reduce dependence on cross-border logistics subject to changing trade policy. These adaptive strategies serve to preserve operational continuity while maintaining the technical and environmental standards that underpin the adoption of bio-based materials.

Differentiated adoption patterns across tire type, end-use channel, material composition, and construction format inform targeted commercialization strategies

Segmentation analysis reveals distinct adoption dynamics across tire types, end-use channels, material categories, and construction methods, and these differences are instrumental for prioritizing commercialization efforts. For example, based on Tire Type, the market is studied across Heavy Commercial Vehicle, Light Commercial Vehicle, Off The Road, Passenger Car, and Two Wheeler, and adoption timelines and performance priorities vary significantly among these groups; heavy commercial applications emphasize load-bearing durability and retread compatibility, while passenger car segments focus more on rolling resistance and noise characteristics.

Similarly, based on End Use, the market is studied across OEM and Replacement, which highlights divergent buyer behavior and specification pathways; OEM programs often require long-term validation and supplier integration, whereas replacement channels are driven by aftermarket performance perception and distributor procurement economics. Material Type segmentation differentiates between Bio Based Polymers, Natural Rubber, and Synthetic Rubber, each of which brings distinct property sets and supply chain considerations that influence R&D focus and supplier selection.

Construction-related segmentation, based on Construction, evaluates Bias and Radial formats, which have implications for manufacturing processes and design adaptation. Taken together, these segmentation lenses enable stakeholders to identify near-term commercialization pockets and tailor product development, testing protocols, and go-to-market models to the specific technical and commercial requirements of each segment.

Regional regulatory frameworks, raw material availability, and industrial ecosystems drive distinct commercialization pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics play a decisive role in shaping supply chains, regulatory landscapes, and customer expectations, and understanding geographic variation is critical when planning production and market entry. In the Americas, demand-side pressure from fleet electrification pilots and sustainability commitments is creating targeted opportunities for lower-rolling-resistance and bio-based formulations, while North American manufacturing capabilities and raw material access influence the pace at which novel compounds can be integrated into production lines.

Across Europe, Middle East & Africa, regulatory frameworks, extended producer responsibility initiatives, and consumer expectations around circularity are particularly influential; these factors encourage collaboration between tire makers and recyclers, and they prioritize transparency around feedstock provenance. In Asia-Pacific, the combination of large-scale vehicle production hubs, diverse regulatory regimes, and proximity to natural rubber sources creates a heterogeneous landscape where both scale and cost competitiveness are decisive.

Consequently, regional strategies must align R&D priorities, supplier networks, and certification efforts with local market drivers. For firms expanding internationally, this means tailoring product specifications and validation timelines to regional testing standards and end-user expectations while leveraging local partnerships to accelerate adoption and manage logistics efficiently.

Companies are deploying a mix of proprietary material development, upstream feedstock partnerships, and manufacturing flexibility to validate performance and accelerate commercialization

Key industry players are advancing differentiated strategies across research, supply chain integration, and commercialization. Some firms are prioritizing deep investment in proprietary bio-based polymer formulations and performance optimization, focusing on laboratory-to-pilot transitions that preserve handling and durability characteristics. These investments are frequently coupled with collaborative pilot programs involving OEMs and fleet operators to gather longitudinal performance data and to validate retrievability and retread performance under real-world conditions.

Other organizations are concentrating on upstream moves: securing secured access to biogenic feedstocks, establishing traceability systems, and building partnerships with agricultural suppliers to ensure consistent quality and compliance with sustainability criteria. Meanwhile, a subset of manufacturers is optimizing manufacturing flexibility by retrofitting compounding and curing lines to accommodate multiple formulations, enabling a staged scale-up without requiring entirely new production facilities.

Across the landscape, service providers and testing houses are increasingly important, offering accelerated aging, wet traction, and rolling resistance protocols adapted to bio-based chemistries. These third-party validations help mitigate adoption risk, support warranty discussions, and provide impartial evidence needed for OEM qualification. Ultimately, companies that combine technical differentiation with pragmatic supply chain and validation strategies will shape early market leadership.

Prioritize pragmatic R&D validation, resilient feedstock strategies, and modular manufacturing upgrades to de-risk commercialization and meet OEM and regulator expectations

Industry leaders should prioritize a set of pragmatic actions that balance technical rigor with commercial realism. First, allocate targeted R&D resources to close performance gaps that matter to end customers, such as wet grip and rolling resistance, while maintaining a disciplined testing regimen that includes long-duration field validations with representative fleets. These efforts should be paired with structured pilot programs that outline clear success criteria and data-sharing protocols to accelerate OEM qualification.

Second, secure feedstock resilience through diversified sourcing strategies and strategic partnerships with agricultural suppliers and biopolymer producers. This reduces exposure to single-source disruptions and enables better control of traceability and sustainability claims. Third, invest in manufacturing adaptability by implementing modular compounding systems and retrofitting existing curing lines to accept alternative formulations; this lowers the capital barrier for staged commercialization and allows for iterative improvement based on field feedback.

Finally, engage early with regulators, recyclers, and standard-setting bodies to ensure that new materials are aligned with evolving compliance expectations and end-of-life infrastructure. By combining rigorous performance validation, resilient sourcing, flexible manufacturing, and proactive regulatory engagement, companies can de-risk market entry and build credible value propositions for OEMs and aftermarket stakeholders.

A mixed-methods approach combining primary interviews, laboratory validation reviews, and operational pilot assessments to align technical feasibility with commercial realities

This analysis synthesizes primary qualitative interviews, materials science literature, and cross-functional operational benchmarks to construct a rigorous view of commercialization dynamics. Primary inputs included structured interviews with material scientists, procurement leaders, production engineers, and fleet operations managers, supplemented by site visits and pilot program debriefs that provided practical insights into manufacturing integration challenges and field performance trade-offs.

Laboratory and certification testing protocols were reviewed to assess the state of performance parity for bio-based compounds, with emphasis on durability, wet traction, rolling resistance, and retreadability. Supply chain assessments examined feedstock sourcing options, traceability mechanisms, and the logistical implications of regionalized production strategies. Additionally, stakeholder workshops were convened to validate assumptions and to surface commercially relevant success criteria for OEM qualification.

All findings were triangulated to reconcile laboratory performance claims with operational realities observed in pilot deployments. This mixed-methods approach ensures that recommendations reflect both technical feasibility and commercial applicability, enabling industry leaders to plan realistic, phased adoption roadmaps that address immediate performance concerns while preparing for longer-term sustainability objectives.

Iterative technical validation, pragmatic supply chain alignment, and collaborative partnerships will determine which organizations lead the transition to commercially viable biobased tire solutions

The path forward for biobased tires is neither linear nor homogeneous; instead, it will be defined by iterative technical progress, targeted commercial pilots, and region-sensitive supply chain choices. Technical advances are steadily narrowing performance gaps, but broad adoption will require sustained investment in validation programs that translate laboratory improvements into demonstrable in-service reliability. Concurrently, regulatory momentum and shifting procurement priorities are exerting pressure on manufacturers to incorporate environmental credentials into their core product narratives.

Successful adoption will hinge on firms that integrate material innovation with operational pragmatism: securing reliable feedstock pathways, investing in flexible manufacturing systems, and building compelling, evidence-based stories for OEM buyers and fleet managers. Collaboration will be essential-across suppliers, OEMs, testing houses, and recyclers-to create coherent value chains that support both initial deployments and scalable rollouts. In sum, the near-term horizon favors those who can deliver verifiable performance parity while managing cost, availability, and regulatory expectations in parallel.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biobased Tires Market, by Tire Type

• 8.1. Heavy Commercial Vehicle
• 8.2. Light Commercial Vehicle
• 8.3. Off The Road
• 8.4. Passenger Car
• 8.5. Two Wheeler

9. Biobased Tires Market, by Construction

• 9.1. Bias
• 9.2. Radial

10. Biobased Tires Market, by Material Type

• 10.1. Bio Based Polymers
• 10.2. Natural Rubber
• 10.3. Synthetic Rubber

11. Biobased Tires Market, by End Use

• 11.1. OEM
• 11.2. Replacement

12. Biobased Tires Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Biobased Tires Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Biobased Tires Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Biobased Tires Market

16. China Biobased Tires Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Apollo Tyres Limited
• 17.6. Birla Carbon
• 17.7. Bridgestone Corporation
• 17.8. CEAT Limited
• 17.9. Compagnie Generale des Etablissements Michelin S.C.A.
• 17.10. Continental Aktiengesellschaft
• 17.11. Evonik Industries AG
• 17.12. Hankook Tire & Technology Co., Ltd.
• 17.13. JK Tyre & Industries Ltd.
• 17.14. Kumho Tire Co., Inc.
• 17.15. Pirelli & C. S.p.A.
• 17.16. Sailun Group Co., Ltd.
• 17.17. Solvay
• 17.18. Sumitomo Rubber Industries, Ltd.
• 17.19. The Goodyear Tire & Rubber Company
• 17.20. Titan International, Inc.
• 17.21. Toyo Tire Corporation
• 17.22. Yokohama Rubber Co., Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL BIOBASED TIRES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL BIOBASED TIRES MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL BIOBASED TIRES MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL BIOBASED TIRES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL BIOBASED TIRES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL BIOBASED TIRES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES BIOBASED TIRES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA BIOBASED TIRES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL BIOBASED TIRES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL BIOBASED TIRES MARKET SIZE, BY HEAVY COMMERCIAL VEHICLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL BIOBASED TIRES MARKET SIZE, BY HEAVY COMMERCIAL VEHICLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL BIOBASED TIRES MARKET SIZE, BY HEAVY COMMERCIAL VEHICLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL BIOBASED TIRES MARKET SIZE, BY LIGHT COMMERCIAL VEHICLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL BIOBASED TIRES MARKET SIZE, BY LIGHT COMMERCIAL VEHICLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL BIOBASED TIRES MARKET SIZE, BY LIGHT COMMERCIAL VEHICLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL BIOBASED TIRES MARKET SIZE, BY OFF THE ROAD, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL BIOBASED TIRES MARKET SIZE, BY OFF THE ROAD, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL BIOBASED TIRES MARKET SIZE, BY OFF THE ROAD, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL BIOBASED TIRES MARKET SIZE, BY PASSENGER CAR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL BIOBASED TIRES MARKET SIZE, BY PASSENGER CAR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL BIOBASED TIRES MARKET SIZE, BY PASSENGER CAR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL BIOBASED TIRES MARKET SIZE, BY TWO WHEELER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL BIOBASED TIRES MARKET SIZE, BY TWO WHEELER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL BIOBASED TIRES MARKET SIZE, BY TWO WHEELER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL BIOBASED TIRES MARKET SIZE, BY BIAS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL BIOBASED TIRES MARKET SIZE, BY BIAS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL BIOBASED TIRES MARKET SIZE, BY BIAS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL BIOBASED TIRES MARKET SIZE, BY RADIAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL BIOBASED TIRES MARKET SIZE, BY RADIAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL BIOBASED TIRES MARKET SIZE, BY RADIAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL BIOBASED TIRES MARKET SIZE, BY BIO BASED POLYMERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL BIOBASED TIRES MARKET SIZE, BY BIO BASED POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL BIOBASED TIRES MARKET SIZE, BY BIO BASED POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL BIOBASED TIRES MARKET SIZE, BY NATURAL RUBBER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL BIOBASED TIRES MARKET SIZE, BY NATURAL RUBBER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL BIOBASED TIRES MARKET SIZE, BY NATURAL RUBBER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL BIOBASED TIRES MARKET SIZE, BY SYNTHETIC RUBBER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL BIOBASED TIRES MARKET SIZE, BY SYNTHETIC RUBBER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL BIOBASED TIRES MARKET SIZE, BY SYNTHETIC RUBBER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL BIOBASED TIRES MARKET SIZE, BY OEM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL BIOBASED TIRES MARKET SIZE, BY OEM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL BIOBASED TIRES MARKET SIZE, BY OEM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL BIOBASED TIRES MARKET SIZE, BY REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL BIOBASED TIRES MARKET SIZE, BY REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL BIOBASED TIRES MARKET SIZE, BY REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL BIOBASED TIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. AMERICAS BIOBASED TIRES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 44. AMERICAS BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 45. AMERICAS BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 46. AMERICAS BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 47. AMERICAS BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 48. NORTH AMERICA BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. NORTH AMERICA BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 50. NORTH AMERICA BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 51. NORTH AMERICA BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 52. NORTH AMERICA BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 53. LATIN AMERICA BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 54. LATIN AMERICA BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 55. LATIN AMERICA BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 56. LATIN AMERICA BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 57. LATIN AMERICA BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOBASED TIRES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 63. EUROPE BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 64. EUROPE BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 65. EUROPE BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 66. EUROPE BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 67. EUROPE BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 68. MIDDLE EAST BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. MIDDLE EAST BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 70. MIDDLE EAST BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 71. MIDDLE EAST BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 72. MIDDLE EAST BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 73. AFRICA BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 74. AFRICA BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 75. AFRICA BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 76. AFRICA BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 77. AFRICA BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 78. ASIA-PACIFIC BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. ASIA-PACIFIC BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 80. ASIA-PACIFIC BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 81. ASIA-PACIFIC BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 82. ASIA-PACIFIC BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL BIOBASED TIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 84. ASEAN BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 85. ASEAN BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 86. ASEAN BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 87. ASEAN BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 88. ASEAN BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 89. GCC BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 90. GCC BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 91. GCC BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 92. GCC BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 93. GCC BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 94. EUROPEAN UNION BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 95. EUROPEAN UNION BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 96. EUROPEAN UNION BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 97. EUROPEAN UNION BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 98. EUROPEAN UNION BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 99. BRICS BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. BRICS BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 101. BRICS BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 102. BRICS BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 103. BRICS BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 104. G7 BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 105. G7 BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 106. G7 BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 107. G7 BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 108. G7 BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 109. NATO BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 110. NATO BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 111. NATO BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 112. NATO BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 113. NATO BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 114. GLOBAL BIOBASED TIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 115. UNITED STATES BIOBASED TIRES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 116. UNITED STATES BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 117. UNITED STATES BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 118. UNITED STATES BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 119. UNITED STATES BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
• TABLE 120. CHINA BIOBASED TIRES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 121. CHINA BIOBASED TIRES MARKET SIZE, BY TIRE TYPE, 2018-2032 (USD MILLION)
• TABLE 122. CHINA BIOBASED TIRES MARKET SIZE, BY CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 123. CHINA BIOBASED TIRES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 124. CHINA BIOBASED TIRES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)